Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus

Clinical and Vaccine Immunology

Volumn 18, Issue 12, 2011, Pages 2031-2037

  Ghiasi, S M ^a   Salmanian, A H ^a   Chinikar, S ^b   Zakeri, S ^b  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EDIBLE VACCINE; GLYCOPROTEIN G1 G2 VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INACTIVATED CRIMEAN CONGO HEMORRHAGIC FEVER VACCINE; PLANT PURIFIED GLYCOPROTEIN G1 G2 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; CROSS REACTION; DRUG EFFICACY; FECES ANALYSIS; FEMALE; GLYCOPROTEIN G1 G2 GENE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NAIRO VIRUS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PLANT LEAF; PLANT ROOT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STABLE TRANSFECTION; TOBACCO; TRANSGENIC PLANT; VIRUS GENE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; FECES; GLYCOPROTEINS; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; PLANTS, GENETICALLY MODIFIED; SERUM; TOBACCO; VACCINES, EDIBLE; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

EID: 83455259591     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05352-11     Document Type: Article

References (52)

1. Ahmed, A. A., et al. 2005. Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virus. J. Gen. Virol. 86:3327-3336. (Pubitemid 41685165)
2. Alvarez, M. L., et al. 2006. Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Vaccine 24:2477-2490. (Pubitemid 43292512)
3. Amani, J., S. L. Mousavi, S. Rafati, and A. H. Salmanian. 2011. Immunogenicity of a plant-derived edible chimeric EspA, intimin and Tir of Escherichia coli O157:H7 in mice. Plant Sci. 180:620-627.
4. Arlen, P. A., et al. 2008. Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect. Immun. 76:3640-3650.
5. Bente, D. A., et al. 2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 84:11089-11100.
6. Bertolotti-Ciarlet, A., et al. 2005. Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J. Virol. 79:6152-6161. (Pubitemid 40617220)
7. Borisjuk, N. V., et al. 1999. Production of recombinant proteins in plant root exudates. Nat. Biotechnol. 17:466-469. (Pubitemid 29217899)
8. Boyaka, P. N., et al. 2003. Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity. Curr. Pharm. Des. 9:1965-1972. (Pubitemid 37010102)
9. Boyaka, P. N., et al. 2003. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. J. Immunol. 170:5636-5643. (Pubitemid 36617855)
10. Bramwell, V. W., and Y. Perrie. 2005. The rational design of vaccines. Drug Discov. Today 10:1527-1534. (Pubitemid 41527195)
11. Burt, F. J., and R. Swanepoel. 2005. Molecular epidemiology of African and Asian Crimean-Congo haemorrhagic fever isolates. Epidemiol. Infect. 133:659-666. (Pubitemid 41015556)
12. Burt, F. J., R. Swanepoel, and L. E. Braack. 1993. Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates. Epidemiol. Infect. 111:547-557. (Pubitemid 24015220)
13. Chia, M. Y., et al. 2010. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant. Vet. Immunol. Immunopathol. 135:234-242.
14. Chinikar, S., S. M. Ghiasi, R. Hewson, M. Moradi, and A. Haeri. 2010. Crimean-Congo hemorrhagic fever in Iran and neighboring countries. J. Clin. Virol. 47:110-114.
15. Daniell, H., N. D. Singh, H. Mason, and S. J. Streatfield. 2009. Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci. 14:669-679.
16. D'Aoust, M. A., et al. 2008. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol. J. 6:930-940.
17. Dellaporta, S. L., J. Wood, and J. B. Hicks. 1983. A plant DNA minipreparation: version II. Plant Mol. Biol. Rep. 1:19-21.
18. Deyde, V. M., M. L. Khristova, P. E. Rollin, T. G. Ksiazek, and S. T. Nichol. 2006. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol. 80:8834-8842. (Pubitemid 44384893)
19. Di Maro, A., et al. 2010. Purification and characterization of a viral chitinase active against plant pathogens and herbivores from transgenic tobacco. J. Biotechnol. 147:1-6.
20. Drake, P. M., et al. 2010. Generation of transgenic plants expressing antibodies to the environmental pollutant microcystin-LR. FASEB J. 24:882-890.
21. Ergonul, O. 2006. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 6:203-214.
22. Ergonul, O. 2008. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res. 78:125-131.
23. Flick, R., and C. A. Whitehouse. 2005. Crimean-Congo hemorrhagic fever virus. Curr. Mol. Med. 5:753-760. (Pubitemid 43009515)
24. Geisbert, T. W., D. G. Bausch, and H. Feldmann. 2010. Prospects for immunisation against Marburg and Ebola viruses. Rev. Med. Virol. 20:344-357.
25. Hoogstraal, H. 1979. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol. 15:307-417.
26. Konduru, K., et al. 2011. Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice. Vaccine 29:2968-2977.
27. Kostrzak, A., et al. 2009. Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Vaccine 27:4798-4807.
28. Lajeunesse, M., Q. Zhang, and A. Finn. 2004. Mucosal immunity to infections and its importance in future vaccinology. Adv. Exp. Med. Biol. 549:13-22. (Pubitemid 38968175)
29. Levine, M. M., and M. B. Sztein. 2004. Vaccine development strategies for improving immunization: the role of modern immunology. Nat. Immunol. 5:460-464. (Pubitemid 38660452)
30. Li, J. T., et al. 2006. Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations. Virology 356:171-178.
31. Maltezou, H. C., et al. 2010. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro. Surveill. 15:19504.
32. Mason, H. S., and C. J. Arntzen. 1995. Transgenic plants as vaccine production systems. Trends Biotechnol. 13:388-392.
33. Mason, H. S., T. A. Haq, J. D. Clements, and C. J. Arntzen. 1998. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16:1336-1343. (Pubitemid 28312443)
34. Modelska, A., et al. 1998. Immunization against rabies with plant-derived antigen. Proc. Natl. Acad. Sci. U. S. A. 95:2481-2485. (Pubitemid 28145967)
35. Neutra, M. R., and P. A. Kozlowski. 2006. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6:148-158. (Pubitemid 43361590)
36. Papa, A., E. Papadimitriou, and I. Christova. 2011. The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain. Scand. J. Infect. Dis. 43:225-229.
37. Pizzuti, F., and L. Daroda. 2008. Investigating recombinant protein exudation from roots of transgenic tobacco. Environ. Biosafety Res. 7:219-226.
38. Richardson, J. S., J. D. Dekker, M. A. Croyle, and G. P. Kobinger. 2010. Recent advances in Ebolavirus vaccine development. Hum. Vaccin. 6:439-449.
39. Roy, S., et al. 2010. Rabies glycoprotein fused with B subunit of cholera toxin expressed in tobacco plants folds into biologically active pentameric protein. Protein Expr. Purif 70:184-190.
40. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
41. Sanchez, A. J., M. J. Vincent, and S. T. Nichol. 2002. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. 76:7263-7275.
42. Schwarz, T., T. F. Schwarz, H. Nsanze, and A. M. Ameen. 1997. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection 25:364-367. (Pubitemid 27507306)
43. Spik, K., et al. 2006. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. Vaccine 24:4657-4666. (Pubitemid 43776769)
44. Streatfield, S. J. 2006. Mucosal immunization using recombinant plant-based oral vaccines. Methods 38:150-157. (Pubitemid 43163476)
45. Sullivan, N. J., et al. 2006. Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. PLoS Med. 3:e177.
46. Tacket, C. O., et al. 1998. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4:607-609. (Pubitemid 28237361)
47. Tasdelen Fisgin, N., O. Ergonul, L. Doganci, and N. Tulek. 2009. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur. J. Clin. Microbiol. Infect. Dis. 28:929-933.
48. Thanavala, Y., et al. 2005. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl. Acad. Sci. U. S. A. 102:3378-3382. (Pubitemid 40328053)
49. Topping, J. F. 1998. Tobacco transformation. Methods Mol. Biol. 81:365-372.
50. Whitehouse, C. A. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res. 64:145-160. (Pubitemid 39506835)
51. Woods, R. R., B. C. Geyer, and T. S. Mor. 2008. Hairy-root organ cultures for the production of human acetylcholinesterase. BMC Biotechnol. 8:95.
52. Yen, Y. C., et al. 1985. Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China. Am. J. Trop. Med. Hyg. 34:1179-1182.